Amphetamine_Sulfate
Category
Amphetamine_Sulfate Brand names, Amphetamine_Sulfate Analogs
Amphetamine_Sulfate Brand Names Mixture
Adderall (amphetamine + dextroamphetamine) Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate) Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate) Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate) Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate) Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate) Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
Amphetamine_Sulfate Chemical_Formula
C9H13N
Amphetamine_Sulfate RX_link
http://www.rxlist.com/cgi/generic3/adderallxr.htm
Amphetamine_Sulfate fda sheet
Amphetamine_Sulfate msds (material safety sheet)
Amphetamine_Sulfate Synthesis Reference
U. S. Pat. 1,879,003, (1932)
Amphetamine_Sulfate Molecular Weight
135.206 g/mol
Amphetamine_Sulfate Melting Point
Volatizes slowly at room temperature
Amphetamine_Sulfate H2O Solubility
Slightly
Amphetamine_Sulfate State
Solid
Amphetamine_Sulfate LogP
1.799
Amphetamine_Sulfate Dosage Forms
Capsules
Amphetamine_Sulfate Indication
For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.
Amphetamine_Sulfate Pharmacology
Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.
Amphetamine_Sulfate Absorption
It forms easily absorbed molecules that are highly lipid soluble
Amphetamine_Sulfate Toxicity
LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.
Amphetamine_Sulfate Patient Information
Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.
Amphetamine_Sulfate Organisms Affected
Humans and other mammals